Down-regulation of MHC class I by the Marek's disease virus (MDV) UL49.5 gene product mildly affects virulence in a haplotype-specific fashion  by Jarosinski, Keith W. et al.
Virology 405 (2010) 457–463
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roDown-regulation of MHC class I by the Marek's disease virus (MDV) UL49.5 gene
product mildly affects virulence in a haplotype-speciﬁc fashion
Keith W. Jarosinski a,⁎, Henry D. Hunt b, Nikolaus Osterrieder a,c
a Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA
b USDA-ARS Avian Disease and Oncology Laboratory, 3606 E. Mount Hope Rd., East Lansing, MI 48823, USA
c Institut für Virologie, Freie Universität Berlin, Philippstraße 13, 10115 Berlin, Germany⁎ Corresponding author. Fax: +1 607 253 3384.
E-mail address: kwj4@cornell.edu (K.W. Jarosinski).
0042-6822/$ – see front matter © 2010 Elsevier Inc. A
doi:10.1016/j.virol.2010.06.041a b s t r a c ta r t i c l e i n f oArticle history:
Received 16 March 2010
Returned to author for revision 3 May 2010
Accepted 23 June 2010







down-regulationMarek's disease is a devastating neoplastic disease of chickens caused by Marek's disease virus (MDV). MDV
down-regulates surface expression of MHC class I molecules, although the mechanism has remained elusive.
MDV harbors a UL49.5 homolog that has been shown to down-regulate MHC class I expression in other
Varicelloviruses. Using in vitro assays, we showed that MDV pUL49.5 down-regulates MHC class I directly and
identiﬁed its cytoplasmic tail as essential for this function. In vivo, viruses lacking the cytoplasmic tail of
pUL49.5 showed no differences in MD pathogenesis compared to revertant viruses in highly susceptible
chickens of the B19B19 MHC class I haplotype, while there was a mild reduction in pathogenic potential of the
deletion viruses in chickens more resistant to MD pathogenesis (MHC:B21B21). We concluded that the
pathogenic effect of MHC class I down-regulation mediated by pUL49.5 is small because virus immune
evasion possibly requires more than one viral protein.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Marek's disease (MD) is a lymphoproliferative disease of chickens
that affects most visceral organs and peripheral nerves. MD is caused
by a highly contagious, cell-associated, oncogenic alphaherpesvirus
called Marek's disease virus (MDV), also known as gallid herpesvirus
2 (GaHV-2). Like other herpesviruses, MDV has both a lytic and latent
phase of infection. MDV initially infects B lymphocytes where it
replicates lytically, which is followed by infection of activated T
lymphocytes. Latency is established predominantly in CD4+ T
lymphocytes, and lymphomas usually develop in susceptible chickens
after 3 weeks post-infection (Calnek, 2001).
Escape of immune surveillance is crucial for the development and
maintenance of the latent stage of infection and completion of the
herpesvirus life cycle following reactivation and transmission to
sentinels. Interference with major histocompatibility complex (MHC)
proteins is a commonmechanism targeted by a number of mammalian
alphaherpesviruses to evade this important immune surveillance. For
example, herpes simplex virus type 1 (HSV-1) down-regulates MHC
class I surface expression by interferingwith peptide loading via a direct
interaction of the viral protein ICP47 with the transporter associated
with antigen presentation (TAP) (Fruh et al., 1995; Hill et al., 1995).
Other alphaherpesviruses like equine herpesvirus type 1 (EHV-1),bovine herpesvirus type 1 (BHV-1), and pseudorabies virus (PRV) also
down-regulate MHC class I surface expression, but do not encode an
ICP47 homolog. It has been shown that the gene products of the UL49.5
orthologs will also mediate MHC class I down-regulation, at least in the
case of BHV-1 and PRV, by blocking peptides transported by TAP.
Simultaneously, the BHV-1 UL49.5 product induces degradation of TAP,
the latter function being linked to the cytoplasmic tail of the pUL49.5
(Koppers-Lalic et al., 2003, 2005). Subsequently, it was shown that the
UL49.5 proteins (pUL49.5) of EHV-1 (gene 10) and PRV, which is
glycosylated in this virus and referred to as glycoprotein N (gN), also
inactivate TAP, while the varicella-zoster virus (VZV) pUL49.5 homolog
encoded by ORF9A does not (Koppers-Lalic et al., 2005).
It has been previously shown that MDV down-regulates cell
surface expression of MHC class I proteins during active, but not latent
infection of chicken cells (Hunt et al., 2001). MDV does not contain an
ICP47 homolog but harbors a UL49.5 homolog, which represents a
small type 1 transmembrane protein that is encoded by a gene located
between the UL49 and UL50 open reading frames (Fig. 1). In contrast
to other alphaherpesviruses, the UL49.5 product and its complex
partner, glycoprotein M, were shown to be essential for cell-to-cell
spread of MDV in vitro (Tischer et al., 2002).
In this report, we assessed the contribution of the MDV pUL49.5
during down-regulation of MHC class I surface expression and
pathogenesis of MD. We were able to show that pUL49.5 and, more
speciﬁcally, its short cytoplasmic tail are clearly responsible for
signiﬁcant down-modulation of MHC class I on the surface of
transfected and infected cells. Interestingly, inability to down-
Fig. 1. Schematic representation of theMDVgenome, location ofUL49.5, and the sequence
ofMDVpUL49.5. (A) Genomic structure ofMDV showing the repeat (TRL, IRL, TRS, and IRS)
and unique (UL and US) regions. (B) UL49.5 is located between UL49 and UL50 coding in
the leftwarddirection. (C)Protein sequence ofMDVpUL49.5 indicating signal cleavage site
(arrow), transmembranedomain (gray highlight), andpeptidesdeletedat the cytoplasmic
tail (Δtail) for generation of pUL49.5Δtail expression plasmids and mutant viruses.
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and virulence of MDV mutants lacking the activity and the effect
proved to be speciﬁc for a certain MHC class I haplotype.
Results
Down-regulation of MHC class I surface expression by MDV pUL49.5
The UL49.5 gene of MDV was modiﬁed by insertion of the coding
sequences for a FLAG epitope after the predicted signal peptide and
was cloned into the mammalian expression vector pcDNA3.1. The
resulting recombinant plasmid was transiently transfected into the
chicken B cell line RP9 and MHC class I surface expression and FLAG-
tagged pUL49.5 were analyzed by ﬂow cytometry at 24 h after
transfection. Flow cytometry analysis (Fig. 2A) showed two popula-
tions of cells, one expressing high levels of MHC class I on the surface
and the other (~20%) expressing signiﬁcantly lower levels of surface
MHC class I (red line indicates cells expressing pUL49.5). MHC class I
surface expression on cells transfected with empty vector pcDNA3.1
was unaffected (dashed lines), while the population of RP9 cells
reactive with the FLAG antibody (red line) showed a clear down-
regulation of MHC class I on the surface (red arrow) of approximately
300 mean channels of ﬂuorescence (MCFs). As a negative control, a
plasmid expressing the HSV-1 pUL49.5 did not down-regulate MHC
class I surface expression (Fig. 2B).
It was previously reported that the cytoplasmic tail of pUL49.5
mediates down-regulation of MHC class I surface expression by
targeting TAP for degradation in the ubiquitin–proteosome pathway
(Koppers-Lalic et al., 2005). We therefore investigated whether the
MDV pUL49.5 cytoplasmic tail was involved in MHC class I down-
modulation. A plasmid expressing pUL49.5 that lacked the cytoplas-
mic tail (49.5Δtail) (Fig. 1C) was tested for its ability to alter MHC
class I surface molecules upon transient expression. Flow cytometry
analyses showed that MHC class I surface expression was unaltered in
RP9 cells transfected with the truncated pUL49.5 expression vector
and was virtually indistinguishable from cells transfected with either
empty vector or the HSV-1 pUL49.5 expression vector (Fig. 2C).
Next, RP9 cell lines stably expressing FLAG-tagged MDV pUL49.5
were generated and surface expression of classical and non-classicalMHC class I as well as MHC class II proteins was examined using ﬂow
cytometry.While classical, peptide-presentingMHC class I was down-
regulated by 260 MCFs in cells expressing MDV pUL49.5 (Fig. 2D), no
effect on cell surface expression of non-classical MHC class I (Fig. 2E)
or MHC class II was observed (Fig. 2F). These results indicated that
MDV pUL49.5 by itself, without the need for additional MDV gene
products, is capable of speciﬁcally down-modulating expression of
classical, peptide-presenting MHC class I surface molecules on the cell
surface. Furthermore, the results conﬁrmed that the cytoplasmic tail
of pUL49.5 mediates the observed down-regulation.
Construction and growth properties of MDVΔ49.5tail mutants
Based on the above ﬁndings and recently published reports on the
ability of the pUL49.5 cytoplasmic tail of members of the Varicello-
viruses in blocking TAP function (Koppers-Lalic et al., 2005), we
constructed two independent recombinant viruses (Table 1, 1130 and
1131) based on the infectious BAC20 clone that had been derived from
an avirulent MDV (Schumacher et al., 2000). The engineered
recombinants lacked the amino acids constituting the cytoplasmic
tail of MDV pUL49.5 (Fig. 1C). The two independent clones were
assessed for their in vitro growth properties and found to be virtually
identical to wild-type v20 (v1084) with respect to plaque sizes
induced in primary chicken embryo cell (CEC) cultures (Fig. 3A) and
multi-step growth kinetics in CEC (Fig. 3B). These results clearly
demonstrated that the deletion of the cytoplasmic tail of pUL49.5 did
not have any negative effect on virus replication. This observationwas
in stark contrast to that with the v20Δ49.5 virus, which was unable to
grow in cultured cells (Tischer et al., 2002).
Down-regulation of MHC class I surface expression by MDV is largely
dependent on expression of an intact UL49.5 gene product
In order to test the role of the MDV pUL49.5 cytoplasmic tail in
down-regulation of MHC class I surface expression, an in vitro assay
was used. The immortalized chicken ﬁbroblast cell line OU2, which
constitutively expresses high levels of surface MHC class I, was
infected with v1084, v1130, or v1131. At various times after infection,
MHC class I surface expression was analyzed using ﬂow cytometry.
Consistent with earlier observations of MDV-induced down-regula-
tion, approximately 75% of v1084-infected cells exhibited low levels
of MHC class I surface expression (Fig. 3C). In contrast, only 32% and
24% of infected cells expressed low levels of surface MHC class I
molecules in the v1130- and v1131-infected cultures, respectively,
showing that down-regulation of MHC class I was greatly reduced
with viruses lacking the pUL49.5 cytoplasmic tail. From these results
we concluded that the MDV pUL49.5 is at least partially responsible
for down-regulation of MHC class I on the cell surface in a virus
context.
Pathogenesis of virulent MDV lacking the cytoplasmic tail of pUL49.5
Our initial studies utilized the BAC20-derived virus (v20, 1084),
which is based on attenuated vaccine strain 584p80C, using in vitro
assays to examine the role of the cytoplasmic tail of MDV pUL49.5 in
down-regulation ofMHC class I surface expression. In order to identify
the contribution of the pUL49.5 cytoplasmic tail during MDV
pathogenesis in vivo, recombinant viruses were generated using the
infectious pRB-1B clone (Petherbridge et al., 2004). Amutant BACwas
generated with a deletion of the UL49.5 cytoplasmic tail (Table 1,
1157). In addition, a revertant virus was constructed in which the
deletion of the cytoplasmic tail was restored (Table 1, 1184).
Consistent with the ﬁndings of the v20Δ49.5tail mutant viruses
(v1130 and v1131), there was no growth defect of the v1157 in vitro
based on plaque size and multi-step growth kinetics compared to its
revertant (v1184) and the parental vRB-1B (v1085) (data not shown).
Fig. 2. Down-regulation of MHC class I surface expression by MDV pUL49.5. (A–C) Flow cytometry analysis of RP9 cells transiently transfected with pcUL49.5 (A), pcHSVUL49.5
(B), or pcUL49.5Δtail (C). MHC class I surface expression following transfection with expression constructs were compared to RP9 cells transfected with the empty vector
(pcDNA3.1). (D–F) Two RP9 cell lines stably expressing either classical (BF2*21) or non-classical (BF1*21) FLAG-taggedMHC class I glycoproteins (Hunt et al., 2001) were transiently
transfected with pcDNA3.1 or pcDNA-UL49.5 and analyzed by ﬂow cytometry for classical (D) and non-classical MHC class I (E), as well as MHC class II (F) surface expression. Red
lines indicate cells expressing MDV pUL49.5 using anti-FLAG antibodies, black lines indicate cells harboring vector only, and dotted curves indicate antibody isotype controls.
459K.W. Jarosinski et al. / Virology 405 (2010) 457–463In a ﬁrst animal trial, the development of MD was examined over
an 8-week period inMD-susceptible P2a chickens infectedwith v1085
(parental vRB-1B), v1157 (Δ49.5tail), or v1184 (Δ49.5tail-rev). By the
termination of the experiment, 85% of chickens infected with the
deletion mutant v1157 developed MD, while 93% and 73% of chickens
infected with v1085 and v1184, respectively, developed MD. Back
titration of viral stocks used in this experiment showed chickens were
infected with 850, 3,000, and only 5 PFU/chicken for v1085, v1157,
and v1184, respectively, which might explain the slightly lower MD
incidence in the v1184 group.
In a second animal trial, both viral replication and the development
of MDwere examined. Analysis of viral replication by quantitative real-
time PCR of viral loads in peripheral blood showed there were no
signiﬁcant differences among the three viruses (Fig. 4A). We were
unable to sample chickens beyond 4 weeks after infection since our
sample size of chickens for analysis was reduced substantially because
of losses due to MD (Fig. 4B). In this experiment, the v1157 deletion
virus induced slightly reduced incidence (82%) compared to 100% forTable 1
Designation of virus by number.
Numbera Originating cloneb Mo
1084 BAC20 (Schumacher et al., 2000; Spatz et al., 2008) Mu
1130 1084 (BAC20) ΔU
1131 1084 (BAC20) ΔU
1085 pRB-1B with US2 restored (Petherbridge et al., 2004;
Spatz et al., 2007; Jarosinski et al., 2007)
US2
1157 1085 (pRB-1B) US2
1184 1157 Rev
1269 None (Jarosinski et al., 2007) US2
1360 1269 US2
1407 1360 Rev
a Designated number based on the bacterial artiﬁcial chromosomes stock number.
b Originating BAC clone that mutations were done in.
c Modiﬁcations compared to the published sequence of Md5 (Tulman et al., 2000).
d Indicates whether the virus horizontally spread to sentinel chickens.
e Previously published (Jarosinski et al., 2007).
f Determined in this study.v1085 (parental) and the 1157 revertant (v1184). The observations of a
slightly reduced oncogenic potential of the RB-1B mutant lacking the
cytoplasmic tail of the UL49.5 protein were similar to the observations
made in theﬁrst animal experiment. The differences, however,were not
statistically signiﬁcant and only represent a trend.
Another important aspect of MDV pathogenesis is that virus is
capable of spreading from chicken-to-chicken by horizontal trans-
mission after being shed from the skin of infected chickens. As
discovered earlier, recombinant virus derived from the original pRB-
1B infectious BAC clone was incapable of horizontal spread; therefore,
we were unable to examine this aspect of MDV pathogenesis in the
ﬁrst two trials. Recently, horizontal transmission was restored in
viruses derived from pRB-1B BAC in which the gC, gD, and UL13 ORFs
containing frame-shift mutations were repaired (Jarosinski et al.,
2007). Using the restored virus, we again deleted the MDV UL49.5
cytoplasmic tail and also generated a revertant virus in which the
cytoplasmic tail was restored (Table 1). In a third animal trial
evaluating viral replication in peripheral blood, MD incidence, anddiﬁcationsc Spreadd
ltiple (Spatz et al., 2008) −
L49.5cytoplasmic tail −
L49.5cytoplasmic tail −
-restored (Jarosinski et al., 2007) −e
-restored; ΔUL49.5 cytoplasmic tail −f
ertant of 1157 −f
-restored; UL13-, gC-, and gD-repaired +e
-restored; UL13-, gC-, and gC-repaired; ΔUL49.5 cytoplasmic tai +f
ertant of 1360 +f
Fig. 3. Plaque size, growth kinetics, and down-regulation of MHC class I surface expression of MDV lacking the UL49.5 cytoplasmic tail. (A) Plaque sizes were measured at 5 days pi as
previously described. No difference was seen between parental (v1084) and two viruses lacking the UL49.5 cytoplasmic tail (v1130 and v1131). (B) Growth kinetics of v1084, v1130,
and v1131 showing no differences between all three viruses. (C) OU2 cells were analyzed by double immunoﬂuorescent staining and FACscan analysis at 72h after co-seeding of
infected with uninfected cells as detailed in the materials and methods. The X-axis (FL-1) represents MHC class I surface expression and the Y-axis (FL-4) represents MDV-speciﬁc
reactivity. The percentage of infected cells with low MHC class I expression was calculated according to the formula: UL/(UL+UR)×100, where UL is the number of cells in the
upper left quadrant (MDVhighMHC-Ilow) and UR is the number of cells in the upper right quadrant (MDVhighMHC-Ihigh).
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v1269 (parental virus that is spread competent), v1360 (Δ49.5tail),
and v1407 (Δ49.5tail-rev) as both mutant and revertant viruses
replicated to similar levels (Fig. 5A), induced 100% MD incidence by
12 weeks (Fig. 5B), and horizontally spread from chicken-to-chickens
with 56% and 88% of contact chickens, respectively, developing MD at
the time of termination (12 weeks). From these results, we concluded
that down-regulation of MHC class I by the MDV UL49.5 gene product
is not a prominent virulence mechanism, at least in highly susceptible
B19B19 chickens.
In a ﬁnal chicken experiment, we examined if the UL49.5
cytoplasmic tail played a role dependent on the MHC haplotype of
the chicken. MD-resistant N2a chickens (B21B21 haplotype) were
infected with v1360 or its revertant (v1407), and viral replication, MD
incidence, and horizontal transmission were measured (Fig. 6). Early
replication (b10 dpi) of v1360 and v1407 were indistinguishable,
whereas there appeared to be a divergence in that there was a rapid
decrease in replication in the v1360 group, followed by an increase
that was maintained until monitoring of replication was stopped
(Fig. 6A). In contrast, the Δ49.5tail-rev group had a slower decrease in
replication from 10 to 21 days pi, which then increased modestly upto 35 days pi. There appeared to be a difference in MD incidence and
horizontal transmission between the two groups as well with the
Δ49.5tail group causing less MD (60%) compared to its revertant
group (87%) and this was also reﬂected in the MD incidence in contact
chickens (17% to 33%, respectively).
Discussion
It was previously shown that MDV can down-regulate MHC class I
surface expression (Hunt et al., 2001). In this report, we show that the
MDV encoded pUL49.5, more speciﬁcally its cytoplasmic tail, is directly
responsible for down-regulation of MHC class I surface expression. We
also were able to show that MDV pUL49.5 can induce this effect in the
absence of other viral proteins. Clearly, transfection of chicken RP9 B
cells with a plasmid expressing FLAG-tagged MDV pUL49.5 down-
regulated MHC class I surface expression in cells expressing pUL49.5
(Fig. 2A), while the HSV-1 UL49.5 expression did not (Fig. 2B). Deletion
of the cytoplasmic tail of MDV pUL49.5 showed that this region was
essential for MHC class I surface down-regulation (Fig. 2C).
In the context of viral infection, the avirulent BAC20 virus was able
to down-regulate MHC class I surface expression following infection
Fig. 4.MDVDNA replication andMD incidence of virus lacking the 49.5 cytoplasmic tail.
(A) MDV genomic copies were quantiﬁed in the whole blood of infected chickens at 7,
14, 21, and 28 days pi by detection of ICP4 DNA for parental (v1085), Δ49.5tail (v1157),
and the Δ49.5tail revertant (v1184) and normalized to the chicken iNOS gene for DNA
loading using qPCR assays. Standard error of the mean (SEM) bars for each group are
shown. (B) Percent of MD incidence was determined for each group during the 12-
week evaluation period.
Fig. 5. MDV DNA replication and MDV incidence of virus lacking the 49.5 cytoplasmic
tail (Δ49.5tail) that can horizontally spread in highly MD-susceptible P2a chickens.
(A) MDV genomic copies were quantiﬁed in the whole blood of parental (v1269)-,
Δ49.5tail (v1360)-, and theΔ49.5tail revertant (v1407)-infected chickens at 4, 7, 10, 14,
21, and 28 days pi as in Fig. 4. SEM bars for each group are shown. (B) Percent of MD
incidence was determined for each group during the 12-week evaluation period.
Fig. 6. MDV DNA replication and MDV incidence of virus lacking the 49.5 cytoplasmic
tail that can horizontally spread inMD-resistant N2a chickens. (A)MDV genomic copies
were quantiﬁed in thewhole blood of infected chickens at 4, 7, 10, 14, 21, and 28 days pi
as in Fig. 4 for v1360 and v1407. SEM bars for each group are shown. (B) Percent of MD
incidence was determined for each group during the 13-week evaluation period.
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expresses high levels of MHC class I on its surface. However, when the
cytoplasmic tail of pUL49.5 was removed in two independent viruses,
the level of MHC class I down-regulation was reduced considerably
(Fig. 3C), results that were consistent with the ﬁndings in the
pUL49.5Δtail expression experiments (Fig. 2).
In order to examine the importance of the MDV pUL49.5
cytoplasmic tail during MDV pathogenesis, we created UL49.5Δtail
mutants based on an infectious clone of the highly virulent RB-1B
strain (pRB-1B). In these studies, we found no difference between
wild-type and revertant viruses compared to viruses lacking the MDV
pUL49.5 cytoplasmic tail after infection of chickens of an MHC
haplotype (B19B19) that is associated with increased susceptibility to
MDV infection (Cole, 1968). In contrast, MDV lacking the cytoplasmic
tail of pUL49.5 were less pathogenic in chickens homozygous for the
B21 MHC allele, suggesting an MHC haplotype-speciﬁc effect of MHC
class I down-regulation in the overall pathogenesis of virulent MDV.
Unfortunately, we were unable to directly examine the down-
regulation affect of vRB-1B in vitro since virulent MDV is selective
for which cell types it will efﬁciently infect in vitro. In multiple
attempts, wewere unable to establish infection in OU2 cells with vRB-
1B (Jarosinski and Osterrieder, unpublished observations). In addition
to the inability of vRB-1B to infect OU2 cells, all cell types in which
propagation of virulent MDV is possible, such as CEC, chicken kidney
cell (CKC), or duck embryo ﬁbroblast (DEF) cultures, do not expresses
signiﬁcant levels of MHC class I on the cell surface (Jarosinski and
Osterrieder, unpublished observations). Additionally, levels of surface
MHC class I on CKC or CEC cultures treated with interferon did not
increase signiﬁcantly enough to show down-regulation with the vRB-
1B lacking the cytoplasmic tail of pUL49.5. Thus, due to technical
462 K.W. Jarosinski et al. / Virology 405 (2010) 457–463limitations we were unable to test MDV pUL49.5 MHC class I down-
regulation properties in the context of a virulent virus in vitro.
At present, we surmise that MDV pUL49.5 down-regulates MHC
class I surface expression on infected cells by blocking peptide transport
by TAP based on results of studies using MDV UL49.5 homologs
including BHV-1 (UL49.5), EHV-1 (gene 10), and PRV (gN) (Koppers-
Lalic et al., 2005). In preliminary experiments, however, we were not
able to demonstrate degradation of TAP, which would hint that MDV
pUL49.5 acts similarly to its EHV-1 counterpart that blocks peptide
transport but does not result in TAP degradation (Koppers-Lalic et al.,
2005). In this context it is important to note that the close relative of
MDV, varicella-zoster virus (VZV), also down-regulates MHC class I
expression, but interestingly the VZVUL49.5 homolog, ORF 9A, does not
mediate this effect although binding of the ORF 9Aproduct to TAP still is
observed (Koppers-Lalic et al., 2005). It was recently shown that the
serine/threonine protein kinase ORF66 (HSV US3 homolog) is able to
mediateMHC class I down-regulation; however, other VZV proteins are
most likely able to down-regulate MHC class I as well since VZV lacking
ORF66 kinase domain still is capable of down-regulating MHC class I
expression (Eisfeld et al., 2007). It is unknown at this time if MDV pUS3
is able to down-regulate MHC class I surface expression or whether this
activity is possibly conferred by other MDV proteins. In vitro experi-
ments with the avirulent BAC20 strain suggest that although mutants
lacking the pUL49.5 cytoplasmic tail fail to down-regulate MHC class I
surface expression as efﬁciently as the parental virus (Fig. 3), there are
still 25-35% infected cells that still maintain low levels of MHC class I
surface expression. These data indicate that (an)other gene product(s)
may also have MHC class I down-regulating activity and may be
important for completeMHC class I surface expression down-regulation
in vitro. This interpretation would also explain the lack of signiﬁcant
pathogenic changes with the virulent MDV lacking the pUL49.5
cytoplasmic tail (Figs. 4–6) and be consistent with the ﬁndings in
murine cytomegalovirus (MCMV) immune evasion where a clear
reduction in virulence was only shown in the absence of a whole set
of genes involved in MHC class I down-regulation (Pinto et al., 2006).
In summary, we have shown that the MDV UL49.5 gene product
down-regulates MHC class I surface expression in vitro in chicken
ﬁbroblast and B cells. This mechanism, however, had little effect in vivo
suggesting that other proteins may be involved during infection in the
chicken. Based on studies addressing pUL49.5 action in related viruses,
our future studieswill focus on the exactmechanismbywhich theMDV
ortholog confers this activity and will ﬁrst concentrate on the putative
TAP interaction in the process. Additionally, we are evaluating other
potential MHC class I down-modulating genes encoded by MDV.
Materials and Methods
Cell cultures and viruses
CEC cultures were prepared from 10-day-old speciﬁc-pathogen-
free (SPF) embryos, while CKC cultures were prepared from 14-day-
old SPF chickens (Schat and Purchase, 1998). CHCC-OU2 (OU2) cells
are a chemically transformed CEC line and have previously been
described (Hunt et al., 2001; Ogura and Fujiwara, 1987). The
lymphoblastoid cell line, LSCC-RP9 (RP9) cells are an avian leukosisTable 2






a Directionality of the primer.
b Underlined sequence indicates the template binding region of the primers for PCR amp
sequence into the Δ49.5 mutant.virus-transformed cell line (B2B15). Both cell lines were grown in
Leibovitz-McCoy medium supplemented with 10% fetal bovine serum
(FBS), 12% tryptose phosphate broth, and antibiotics in a humidiﬁed
atmosphere of 5% CO2, although the OU2 cells were grown at 38 °C,
while RP9 cells were grown at 41 °C.
Recombinant viruses were reconstituted by transfecting CEC
cultures with puriﬁed BAC DNA using the CaPO4 precipitation method
(Schumacher et al., 2000) with pCAGGS-NLS/Cre, a plasmid expressing
the Cre enzyme for excision ofmini-F sequences using loxP sites (a kind
gift from Dr. Michael I. Kotlikoff, Cornell University, Ithaca, NY), as
previously described (Jarosinski et al., 2007). For propagation of
reconstituted viruses, infected CEC cultures were passed onto CKC
cultures after the development of plaques following transfection and
expanded. Recombinant virus stocks were examined for the removal of
mini-F vector sequences as previously described (Jarosinski et al., 2007)
and shown to lack the mini-F vector (data not shown). BAC clones
generated are shown in Table 1 with genome modiﬁcations indicated.
UL49.5 expression vectors and antibodies
To investigate the effects of MDV UL49.5 on MHC class I expression,
the UL49.5 genewas PCR ampliﬁed and cloned into theHindIII/XbaI sites
of the pcDNA3.1/Zeo (Invitrogen, Carlsbad, CA) expression vector
(pcDNA-UL49.5). The UL49.5 insert in the expression plasmid was DNA
sequenced (BigDye® Terminator v3.1 Cycle Sequencing Kit, Life
Technologies, Carlsbad, CA) to assure integrity of the sequence. The
pcDNA-UL49.5 was used for transient expression in RP9 chicken B cell
lines stably expressing either classical (BF2*21) or non-classical (BF1*21)
FLAG-tagged MHC class I glycoproteins (Hunt et al., 2001). Control or
pcDNA-UL49.5 plasmids were transfected into 1×107 RP9 cells with the
Nucleofector II electroporation device from Amaxa (Lonza Walkerrsville
Inc.,Walkersville, MD) using solution V and program T-001. The classical
andnon-classicalMHCclass I expressionwasanalyzedbyﬂowcytometry
(BDFACSCalibur, San Jose, CA)using either theC6B12antibody speciﬁc to
chickenMHCclass I (DSHB,University of Iowa, IowaCity, Iowa)or theM1
anti-FLAG monoclonal antibody (Sigma Chemical Company, St. Louis,
MO) and detected with ﬂuorescein isothiocyanate-labeled goat anti
mouse (Cappel, Durham, NC) 24 and 48 h after transfection.
Construction of 49.5Δtail recombinant MDV
Mutagenesis was performed as using two-step Red recombination
exactly as previously described (Jarosinski et al., 2007) with primers
shown in Table 2. All ﬁnal clones were screened by restriction
fragment length polymorphism, Southern blot, and nucleotide
sequencing analyses for conﬁrmation purposes.
Blood DNA extraction and qPCR
DNA was extracted from whole blood for use in qPCR exactly as
previously described (Jarosinski et al., 2007) using the DNeasy® 96
Tissue Kit from Qiagen, Inc. (Valencia, CA). Quantiﬁcation of MDV
genomic copies using qPCR was also performed exactly as previously
described (Jarosinski et al., 2007) using primers, and probe speciﬁc for




liﬁcation with pEPKanS. Bold indicates the insertion of the cytoplasmic tail nucleotide
463K.W. Jarosinski et al. / Virology 405 (2010) 457–463in an ABI Prism 7500 Fast Real-time PCR System (Applied Biosystems,
Inc.) and the results were analyzed using Sequence Detection Systems
version 1.4 software supplied by the manufacturer. Using the standard
curve generated for each gene, the number of copies for ICP4 and iNOS
was determined by using the CT value for that sample.
Multi-step growth kinetics and measurement of plaque areas
Multi-step growth kinetic analysis was determined as previously
described (Dorange et al., 2002). Brieﬂy, 1×106 CEC were infected
with 100 PFU of each respective virus, and at various times following
infection, infected cells were trypsinized and plated onto fresh CEC at
serial 10-fold dilutions in triplicate. After 5 days pi, cells were ﬁxed
with 90% ice-cold acetone and indirect immunoﬂuorescence using
polyclonal anti-MDV chicken sera and secondary goat anti-chicken
IgG labeled with Alexa Fluor® 488 (Invitrogen, Inc.) was used to
visualize plaques as previously described (Jarosinski et al., 2005).
Plaque areas were measured exactly as previously described
(Jarosinski et al., 2005) using The National Institutes of Health ImageJ
software (rsb.info.nih.gov/ij/) and means with standard deviations
were determined for each virus.
Experimental infection of chickens
SPF P2a (B19B19) or N2a (B21B21) chickens were inoculated intra-
abdominally with 2,000 PFU of the various viruses at 1 day of age.
Where indicated, sentinel chickens were housed together with
infected birds to determine horizontal spread of virus. Chickens
were evaluated daily for symptoms of MD, euthanized, and examined
for gross lesions when birds showed clinical evidence of MD. Chickens
were obtained from departmental ﬂocks, housed in isolation units,
and water and food were provided ad libitum. All experimental
procedures were conducted in compliance with approved Institu-
tional Animal Care and Use Committee (IACUC) protocols. Chickens
were assigned to treatment groups using a randomization table.
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